Cannabis-based products for pediatric epilepsy: An updated systematic review

@article{Elliott2020CannabisbasedPF,
  title={Cannabis-based products for pediatric epilepsy: An updated systematic review},
  author={Jesse Elliott and Deirdre DeJean and Tammy Clifford and Doug Coyle and Beth K. Potter and Becky Skidmore and Christine Alexander and Alexander E. Repetski and Vijay Shukla and Bl{\'a}thnaid McCoy and George A. Wells},
  journal={Seizure},
  year={2020},
  volume={75},
  pages={18-22}
}
Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients
TLDR
A combination of CBD and THC based products are effective in reducing seizure frequency in a range of epileptic conditions and the inefficacy of the healthcare system in supporting these patients is highlighted.
Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
TLDR
It is necessary to investigate CBD safety, pharmacokinetics and interaction with other AEDs alongside performing double-blinded placebo-controlled trials to obtain conclusive data on its efficacy and safety in the most frequent epilepsies in children, not just in the epileptic encephalopathy.
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
TLDR
A considerable number of pre-clinical and clinical studies have provided strong evidence that phytocannabinoids has anticonvulsant properties, as well as being promising in the treatment of different neuropsychiatric disorders, such as depression, anxiety, post-traumatic stress disorder (PTSD), addiction, neurodegenerative disorders and autism spectrum disorder (ASD).
Cannabidiol in epilepsy: The indications and beyond
  • M. Ryan
  • Medicine, Psychology
    The mental health clinician
  • 2020
TLDR
This article examines 3 cases: 1 of a patient with Lennox-Gastaut syndrome, 1 of off-label use of cannabidiol to treat epilepsy, and 1 of nonprescription forms of cannABidiolto treat epilepsy.
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
TLDR
The guideline expert panel issued a weak recommendation to offer a trial of non-inhaled medical cannabis or cannabinoids, in addition to standard care and management (if not sufficient), for people living with chronic cancer or non-cancer pain.
A review on the syntheses of Dronabinol and Epidiolex as classical cannabinoids with various biological activities including those against SARS-COV2
TLDR
The chemical-synthetic strategies of Dronabinol and Epidiolex from THC and CBD, which can reduce the uncontrolled cytokine production of acute lung injury, are summarized.
What are the informational pathways that shape people’s use of cannabidiol for medical purposes?
TLDR
The results suggest that consumers crowdfunding come to CBD through internally motivated reasons versus exposure to advertisements or other forms of marketing.
...
1
2
...

References

SHOWING 1-10 OF 43 REFERENCES
Cannabis for pediatric epilepsy: protocol for a living systematic review
TLDR
This review aims to provide a comprehensive and up-to-date summary of the available evidence to inform decisions about the use of cannabis in children with treatment-resistant epilepsy as they navigate this rapidly evolving area.
...
1
2
3
4
5
...